Concepedia

Jens Schroeder

JS

Statistics

Publications

7

Citations

550

H-Index

7

Active since

2005

Affiliations

Bayer (Germany)(Current)

University of the Witwatersrand

Bayer (United States)

Discovery Centre

Jens Schroeder is an author at Bayer (Germany) specializing in medicine, recombinant activated factor vii, and hematology.

Publications per year

2005–2022

7

Publications

7

Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS–SOS1 interaction

R.C. Hillig, Brice Sautier, Jens Schroeder et al. · Proceedings of the National Academy of Sciences · 2019 · 379 citations · Full text

, , +17

High-Potential Human Mesenchymal Stem Cells

Claudia Lange, Jens Schroeder, Michael Lioznov et al. · Stem Cells and Development · 2005 · 47 citations

, , +15

Phase I, randomized, double‐blind, placebo‐controlled, single‐dose escalation study of the recombinant factor VIIa variant BAY 86‐6150 in hemophilia

Johnny Mahlangu, M Coetzee, Michael Laffan et al. · Journal of Thrombosis and Haemostasis · 2012 · 38 citations · Full text

, , +9

Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS<sup>G12C</sup>

Jérémie Mortier, Anders Friberg, Volker Badock et al. · ChemMedChem · 2020 · 34 citations · Full text

, , +17

<scp>TRUST</scp> trial: <scp>BAY</scp> 86‐6150 use in haemophilia with inhibitors and assessment for immunogenicity

Johnny Mahlangu, Marion Hardtke, Fred Aswad et al. · Haemophilia · 2016 · 28 citations · Full text

, , +13

1–5 of 7